(Q27685265)
Statements
Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism (English)
0 references
22 August 2013
0 references
56
0 references
16
0 references
6317-29
0 references